These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 5704263)

  • 1. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].
    Kotzaurek R; Hueber EF
    Wien Med Wochenschr; 1968 Nov; 118(47):1014-8. PubMed ID: 5704263
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F; Neuwirth R; Berg G
    Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Benziodarone in the basic treatment of gout].
    Ryckewaert A; Puel M; Kuntz D
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperuricemia and benziodarone].
    Haddad N; Zamouri A; Naccache S
    Tunis Med; 1973; 51(2):103-4. PubMed ID: 4784400
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R; Bresnik W; Müller MM
    Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K; Trnavský K
    Z Rheumatol; 1979; 38(9-10):342-8. PubMed ID: 525067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of benziodarone on hyperuricemia in gout].
    Cottet J; Vittu C
    Presse Med (1893); 1967 May; 75(26):1355-6. PubMed ID: 6026564
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of gout and of certain rheumatisms with hyperuricemia caused by benziodarone].
    Gerbaux JO; Rodhain J
    Rev Rhum Mal Osteoartic; 1968 Mar; 35(3):98-115. PubMed ID: 5302427
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N; Griebsch A; Fink JK
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].
    Blétry O; Cartier P; Hamet M; Clauvel JP
    Nouv Presse Med; 1974 Apr; 3(16):995-9. PubMed ID: 4836472
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Matzkies F
    Fortschr Med; 1978 Aug; 96(32):1619-21. PubMed ID: 680625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hyperuricemia with benziodarone].
    Ravault PP; Vignon G; Lejeune E; Bouvier M; Queneau P
    Presse Therm Clim; 1970; 107(2):74-9. PubMed ID: 5468122
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gout treatment with a dibromine derivative of benzofuran].
    Delbarre F; Auscher C; Saporta L; de Grey A; Danchot J
    Rev Rhum Mal Osteoartic; 1973 Apr; 40(4):275-7. PubMed ID: 4716906
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A
    Rein Foie; 1967; 10():273-92. PubMed ID: 6081455
    [No Abstract]   [Full Text] [Related]  

  • 15. [Benziodarone in the treatment of hyperuricemia].
    Ravera M
    Clin Ter; 1970 Mar; 52(5):407-16. PubMed ID: 5421984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Benziodarone (Amplivix) in the treatment of hyperuricemia].
    Antila V; Elsilä M
    Duodecim; 1969; 85(7):428-30. PubMed ID: 5799173
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of benziodarone on hyperuricemia due to fasting].
    Fellin R; Pagnan A; Fedele D; Novello M; Crepaldi G
    Policlinico Med; 1972; 79(3):151-64. PubMed ID: 5051107
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of benziodarone on hyperuricemia].
    Josef H; Cossermelli W; Debes AC; Kopersztych S
    AMB Rev Assoc Med Bras; 1969 Sep; 15(9):381-2. PubMed ID: 5309746
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and biological effects of a new uric acid lowering substance (benziodaronum) in gout. Results of a 2-year-long study].
    Barcelo P; Santamaria A
    Verh Dtsch Ges Rheumatol; 1969; 1():361-70. PubMed ID: 5403652
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new drug therapy for gout and hyperuricemia. Long term results].
    Masbernard A; Giudicelli CP
    Sem Hop Ther; 1976; 52(7-8):369-74. PubMed ID: 996556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.